targeted sickle cell disease drug - Yahoo Search Results

Ads
related to: targeted sickle cell disease drug
For Physicians: SCD Treatment - Treatment Centers Map

sicklecelldisease-treatment-hcp.com/sign-up
Find an Authorized Treatment Center for your patients with sickle cell disease. Learn about a treatment option for patients diagnosed with sickle cell disease.
Sign Up · HCP Resources · Treatment Centers · Information About Therapy
Types: Treatment Journey PDF, Registration Form, Mechanism Of Action, Safety And Efficacy
Treatment Journey
See the treatment journey

Step by step.

Resources
Downloadable HCP brochure

and more professional resources.

Treatment Journey Video
See the treatment journey

video on the HCP website.

About The Therapy
The science behind the disease

and this treatment option.
New Treatment: LYFGENIA™ - (lovotibeglogene autotemcel)

www.lyfgenia.com/FDA/Approved
View Full Prescribing Information, Including Boxed Warning & Medication Guide. Information For Patients, Caregivers & HCPs. Learn About A Treatment Option.

Search results

- 5 Top Stocks to Buy in June
  Motley Fool via Yahoo Finance· 5 hours ago
  The gene-editing therapy is a one-time cure for the rare blood disorders sickle cell disease and transfusion-dependent beta thalassemia ...
- Agios Breaks Out On 'Buffed Up' Financials After Inking Massive Brain Cancer Deal
  Investor's Business Daily· 5 days ago
  "We see this as a smart deal for the company and also creates a sizable war chest which...
- Gene therapy offers huge potential for combating disease, doctors say
  United Press International via Yahoo News· 2 days ago
  Researchers are engineering ways to alter genes or swap flawed ones with healthy replacements,...
- Earnings call: BioLineRx Q1 2024 results show steady progress
  Investing.com· 4 days ago
  BioLineRx (BLRX) has reported its financial results for the first quarter of 2024, highlighting...
- Agios (AGIO) Up 23% on Selling Brain Cancer Drug Royalty
  Zacks via Yahoo Finance· 4 days ago
  Agios Pharmaceuticals (AGIO) agrees to sell to Royalty Pharma the rights to royalties on potential...
- Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
  Motley Fool via Yahoo Finance· 3 days ago
  If the disease can be cured for the broader patient population, the demand for CGM devices will...
- Small Business - The Andalusia Star-News | The Andalusia Star-News
  The Andalusia Star-News· 2 days ago
  Visiongain has published a new report: Genome Editing Technologies Market Report 2024-2034: Forecasts by Technology (CRISPR, TALEN, ZFN, Meganucleases, Others), by Application (Genetic Engineering ...
- Cell-targeting technology allows researchers to is | Newswise
  Newswise· 5 days ago
  The tool, named Conditional Viral Expression by Ribozyme Guided Degradation (ConVERGD), allows...